Emerging technologies based on mass spectrometry and nuclear magnetic resonance enable the monitoring of hundreds of metabolites from tissues or body fluids, that is, "metabolomics."

Because metabolites change rapidly in response to physiologic perturbations, they represent proximal reporters of disease phenotypes.

The profiling of low molecular weight biochemicals, including lipids, sugars, nucleotides, organic acids, and amino acids, that serve as substrates and products in metabolic pathways is particularly relevant to cardiovascular ...

Esta siendo redirigido al contenido completo...